Compare NBY & ETB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NBY | ETB |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Bankers/Brokers/Service |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.2M | 448.6M |
| IPO Year | 2007 | N/A |
| Metric | NBY | ETB |
|---|---|---|
| Price | $15.78 | $15.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 71.8K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | 6.30% | ★ 8.23% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $10,302,000.00 | N/A |
| Revenue This Year | $23.91 | N/A |
| Revenue Next Year | $32.05 | N/A |
| P/E Ratio | $493.09 | ★ N/A |
| Revenue Growth | ★ 390.34 | N/A |
| 52 Week Low | $0.46 | $11.59 |
| 52 Week High | $19.95 | $14.08 |
| Indicator | NBY | ETB |
|---|---|---|
| Relative Strength Index (RSI) | 69.49 | 46.00 |
| Support Level | $10.42 | $15.33 |
| Resistance Level | $19.95 | $15.48 |
| Average True Range (ATR) | 3.14 | 0.11 |
| MACD | 0.59 | -0.02 |
| Stochastic Oscillator | 73.24 | 27.44 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.